carbidopa 25 mg levodopa 100 mg
INDICATIONS AND USAGE Carbidopa and levodopa tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. Carbidopa allows patients treated for Parkinson's disease to use much lower doses of levodopa. Some patients who responded poorly to levodopa have improved on carbidopa and levodopa tablets. This is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. Carbidopa has not been shown to enhance the intrinsic efficacy of levodopa. Carbidopa may also reduce nausea and vomiting and permit more rapid titration of levodopa.
trupharma, llc
ROUND YELLOW A 47
A 47 ROUND YELLOW
Related Pills
carbidopa 10 mg levodopa 100 mg
trupharma, llc
gabapentin 300 mg
Ascent Pharmaceuticals, Inc
gabapentin 300 mg
Ascent Pharmaceuticals, Inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
CARBIDOPA AND LEVODOPA tablets USP 10 mg/100 mg are light blue to blue, speckled, round, uncoated tablets, debossed with “Λ” on one side and plain on other. They are supplied as follows: 46 NDC 52817-390-10, bottles of 100. NDC 52817-390-50, bottles of 500.
CARBIDOPA AND LEVODOPA tablets USP 25 mg/100 mg are light yellow to yellow, speckled, round, uncoated tablets, debossed with “Λ” on one side and plain on other. They are supplied as follows: 47 NDC 52817-391-10, bottles of 100. NDC 52817-391-50, bottles of 500. NDC 52817-391-00, bottles of 1000.
CARBIDOPA AND LEVODOPA tablets USP 25 mg/250 mg are light blue to blue, speckled, round, uncoated tablets, debossed with “Λ” on one side and plain on other. They are supplied as follows 49 NDC 52817-392-10, bottles of 100. NDC 52817-392-50, bottles of 500. NDC 52817-392-00, bottles of 1000. Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Store in a tightly closed container, protected from light and moisture. Dispense in a tightly closed, light-resistant container. All trademarks are the property of their respective owners. Manufactured by: Rubicon Research Private Limited Ambernath, Dist: Thane, 421506 India Distributed by: TruPharma, LLC Tampa, FL 33609 Revision: 02/23
More pills like ROUND A 47